FDA Inspection 1320024 — Pelican Plasma
The FDA completed an inspection of Pelican Plasma on May 18, 2026 in Shreveport, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 18, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Shreveport, LA (United States)